English
Fischer Medical Ventures Q2 Results
- BSE: 524743
- NSE: FISCHER
- ISIN: INE771F01041
- Sector: Chemical Manufacturing
BSE
69.70
-2.65 (-3.66%)
-2.65 (-3.66%)Volume1.11 L
Updated: Thu 13 Nov, 2025 | 11:53:46
NSE
69.70-3.03 (-4.17%)
-3.03 (-4.17%)Volume1.38 M
Updated: Thu 13 Nov, 2025 | 11:40:41
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹86.31 Cr.(117.64%)
- Operating Profit₹15.74 Cr.(44491.22%)
- Profit After Tax₹13.90 Cr.(4637.78%)
- Operating Margin18.24%(20388.64%)
Note: Comparison is on YoY basis
Quarterly - Fischer Medical Ventures Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 70.56 | 20.07 | 251.65% | 39.62 | 78.10% |
| Depreciation/ Amortization | 0.51 | 0.77 | -33.26% | 0.29 | 78.31% |
| Operating Income | 15.74 | 3.38 | 366.00% | 0.04 | 44491.22% |
| Net Income | 13.90 | 5.01 | 177.46% | 0.29 | 4637.78% |
| Other Operating Expenses Total | 53.62 | 3.48 | 1439.24% | 2.53 | 2019.57% |
| Net Income Before Taxes | 17.26 | 10.18 | 69.65% | 0.21 | 8112.18% |
| Total Revenue | 86.31 | 23.44 | 268.12% | 39.66 | 117.64% |
| Selling/ General/ Admin Expenses Total | 3.75 | 3.16 | 18.68% | 0.51 | 640.61% |
| Diluted Normalized EPS | 0.21 | 0.01 | 2254.73% | 0.01 | 3010.01% |